α-Thalassemia is quite prevalent in the population of Bahrain reaching a frequency of 24.3% based on neonates screening of Hb Bart's in cord blood hemolysates [1] . In a preliminary report we found five different α-thalassemia determinants as the underlying molecular defects for α-thalassemia in our population [2] . The first most common α-thal determinant uncovered in that report was the Saudi-type polyadenylation signal mutation that is found in α2-globin gene (α A total of 1187 patients with α-thalassemia phenotype presentation have been recruited for this investigation. Preliminary diagnosis of α-thalassemia was based on low hematological indices (MCV and MCH) of the red blood cells and/or persistently low hemoglobin levels, along with low or normal levels of HbA2 and absence of iron deficiency [5, 6] . The molecular diagnosis of α-thalassemia was established by using a commercially available α-thalassemia strip assay (α-Globin StripAssay, ViennaLab Diagnostics GmbH) and direct nucleotide sequencing for further confirmation.
The spectrum of phenotype presentations for the (α TSaudi α) genotype combinations ranges between hemoglobin H (Hb H) disease and α-thalassemia trait phenotype with variable severity.
The first molecular defect causing HbH disease in our population is homozygosity for the (α Table 1 . These patients are presented with moderate to severe level of anemia (Hb ranges: 7.4-9.7g/dL). They persistently show Hb H peak fraction on HPLC of their RBC hemolysates with HbH level ranges from 7.5 to 27.2 % of total hemoglobin. In addition, most of these patients are presented with elevated level of reticulocytes (>3.0%), an indication of hematopoitic stress due to persistent anemia. Moreover, significant number of these patients is undergoing infrequent blood transfusion which is in line with variable phenotype presentation of Hb H disease in other populations [7] [8] [9] . Although this genotype is inactivating only two α-globin genes it gives rise to a severe form of Hb H disease whereas the inactivation of three α-globin genes is commonly encountered in Hb H disease [10] . This unusual effect of the (α 
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Bahrain, Alpha-thalassemia, HbH disease, TSaudi, poly A 9.0g/dL to 11.3g/dL ( Table 2) . None of these patients require blood transfusion.
Comparison of hematological parameters between the (α Other genotype combination of the Saudi type poly A signal mutation that we uncovered includes the (-α 3.7 / α T Saudi α) genotype that we found in 52 patients (Table 3 ). In addition, we found 12 patients with the (-α 4.2 /α TSaudi α) genotype. Indeed, both of these genotypes are presented, as expected, with the same level of hematological severity and mild presentation of Hb H disease (Table 3 ). Finally we uncovered 40 patients with the (α TSaudi α/αα) genotype . These simple heterozygotes are consistently presented with α-thalassemia trait phenotype (Table 3 ).
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